Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomoki Todo

Showing results (71-80 of 96) with videos related to

Pageof 10
Sort By:
Scientific Reports|July 29, 2017
MiR-199a Inhibits Secondary Envelopment of Herpes Simplex Virus-1 Through the Downregulation of Cdc42-specific GTPase Activating Protein Localized in Golgi ApparatusKyousuke Kobayashi, Fumiko Suemasa, Hiroshi Sagara, et al.
Molecular Oncology|July 2, 2021
PRRX1 induced by BMP signaling decreases tumorigenesis by epigenetically regulating glioma-initiating cell properties via DNA methyltransferase 3ARyo Tanabe, Kohei Miyazono, Tomoki Todo, et al.
Neuro-Oncology|January 24, 2009
Long-term control of disseminated pleomorphic xanthoastrocytoma with anaplastic features by means of stereotactic irradiationTomoyuki Koga, Akio Morita, Keisuke Maruyama, et al.
Oncotarget|January 18, 2018
Identification of antipsychotic drug fluspirilene as a potential anti-glioma stem cell drugYu Dong, Takuya Furuta, Hemragul Sabit, et al.
Cancer Science|June 3, 2022
Therapeutic advantage of targeting lysosomal membrane integrity supported by lysophagy in malignant gliomaYongwei Jing, Masahiko Kobayashi, Ha Thi Vu, et al.
Cancer Science|May 5, 2026
Triple-Mutated HSV-1 Expressing Soluble B7-1 Plus CTLA-4 Blockade Suppresses Lymph Node Metastasis in Tongue CancerAkinari Sugauchi, Toshihiro Uchihashi, Hirotaka Ito, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 14, 2011
Homozygously deleted gene DACH1 regulates tumor-initiating activity of glioma cellsAkira Watanabe, Hideki Ogiwara, Shogo Ehata, et al.
Molecular Therapy Oncolytics|August 22, 2022
Efficacy of cancer-specific anti-podoplanin CAR-T cells and oncolytic herpes virus G47Δ combination therapy against glioblastomaLushun Chalise, Akira Kato, Masasuke Ohno, et al.
Journal of Neuro-Oncology|October 9, 2014
Strong therapeutic potential of γ-secretase inhibitor MRK003 for CD44-high and CD133-low glioblastoma initiating cellsShingo Tanaka, Mitsutoshi Nakada, Daisuke Yamada, et al.
The Journal of Biological Chemistry|August 14, 2016
Therapeutic Strategy for Targeting Aggressive Malignant Gliomas by Disrupting Their Energy BalanceAhmed M Hegazy, Daisuke Yamada, Masahiko Kobayashi, et al.
Pageof 10

Showing results (71-80 of 96) with videos related to

Sort By:
Pageof 10
Scientific Reports|July 29, 2017
MiR-199a Inhibits Secondary Envelopment of Herpes Simplex Virus-1 Through the Downregulation of Cdc42-specific GTPase Activating Protein Localized in Golgi ApparatusKyousuke Kobayashi, Fumiko Suemasa, Hiroshi Sagara, et al.
Molecular Oncology|July 2, 2021
PRRX1 induced by BMP signaling decreases tumorigenesis by epigenetically regulating glioma-initiating cell properties via DNA methyltransferase 3ARyo Tanabe, Kohei Miyazono, Tomoki Todo, et al.
Neuro-Oncology|January 24, 2009
Long-term control of disseminated pleomorphic xanthoastrocytoma with anaplastic features by means of stereotactic irradiationTomoyuki Koga, Akio Morita, Keisuke Maruyama, et al.
Oncotarget|January 18, 2018
Identification of antipsychotic drug fluspirilene as a potential anti-glioma stem cell drugYu Dong, Takuya Furuta, Hemragul Sabit, et al.
Cancer Science|June 3, 2022
Therapeutic advantage of targeting lysosomal membrane integrity supported by lysophagy in malignant gliomaYongwei Jing, Masahiko Kobayashi, Ha Thi Vu, et al.
Cancer Science|May 5, 2026
Triple-Mutated HSV-1 Expressing Soluble B7-1 Plus CTLA-4 Blockade Suppresses Lymph Node Metastasis in Tongue CancerAkinari Sugauchi, Toshihiro Uchihashi, Hirotaka Ito, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 14, 2011
Homozygously deleted gene DACH1 regulates tumor-initiating activity of glioma cellsAkira Watanabe, Hideki Ogiwara, Shogo Ehata, et al.
Molecular Therapy Oncolytics|August 22, 2022
Efficacy of cancer-specific anti-podoplanin CAR-T cells and oncolytic herpes virus G47Δ combination therapy against glioblastomaLushun Chalise, Akira Kato, Masasuke Ohno, et al.
Journal of Neuro-Oncology|October 9, 2014
Strong therapeutic potential of γ-secretase inhibitor MRK003 for CD44-high and CD133-low glioblastoma initiating cellsShingo Tanaka, Mitsutoshi Nakada, Daisuke Yamada, et al.
The Journal of Biological Chemistry|August 14, 2016
Therapeutic Strategy for Targeting Aggressive Malignant Gliomas by Disrupting Their Energy BalanceAhmed M Hegazy, Daisuke Yamada, Masahiko Kobayashi, et al.
Pageof 10